Patrick Baeuerle

7 Patents

• US125345052026

  Activatable Interleukin-2 Polypeptides and Methods of Use Thereof

  Werewolf Therapeutics, Inc.

  0 cites
• US122757692025

  Activatable Interleukin 12 Polypeptides and Methods of Use Thereof

  Werewolf Therapeutics, Inc.

  0 cites
• US121281022024

  Constrained Conditionally Activated Binding Proteins

  Takeda Pharmaceutical Company Limited

  0 cites
• US120845182024

  Trispecific Binding Proteins and Methods of Use

  HARPOON THERAPEUTICS, Inc.

  0 cites
• US119817162024

  Activatable Interleukin-2 Polypeptides and Methods of Use Thereof

  Werewolf Therapeutics, Inc.

  0 cites
• US119650122024

  Compositions and Methods for TCR Reprogramming Using Fusion Proteins

  TCR2 THERAPEUTICS Inc.

  0 cites
• US118514912023

  Compositions and Methods for TCR Reprogramming Using Fusion Proteins

  TCR2 THERAPEUTICS Inc.

  0 cites